Innovate Growth Capital Fund has invested $2.0 million in EMSCO Scientific Enterprise, Inc., marking its first portfolio investment in the thriving Life Science sector.
Target Information
Innovate Growth Capital Fund has made its inaugural investment of $2.0 million in EMSCO Scientific Enterprise, Inc. (EMSCO), a prominent distributor of research laboratory supplies and services within the Life Science sector. EMSCO specializes in providing high-quality laboratory products essential for scientific research and experiments, catering to a diverse clientele that includes educational institutions, commercial laboratories, and governmental research organizations.
Founded with a mission to support technological advancements in life sciences, EMSCO has established a strong reputation in the market for its reliable service, extensive product range, and commitment to customer satisfaction. The company’s tailored solutions and focus on innovation position it well for continued growth as demand rises for laboratory supplies globally.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The Life Science industry in the United States is experiencing robust growth, driven by increasing investment in research and development as well as a surge in demand for laboratory supplies and
Similar Deals
Avadel Pharmaceuticals plc → XWPharma Ltd.
2025
Innovate Capital
invested in
EMSCO Scientific Enterprise, Inc.
in 2024
in a Other VC deal
Disclosed details
Transaction Size: $2M